Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
暂无分享,去创建一个
Henrik Zetterberg | Susan Landau | Niklas Mattsson | Kaj Blennow | Oskar Hansson | Olof Strandberg | William Jagust | Erik Stomrud | Sebastian Palmqvist | Michael Schöll | W. Jagust | K. Blennow | S. Landau | O. Hansson | H. Zetterberg | N. Mattsson | S. Palmqvist | E. Stomrud | M. Schöll | O. Strandberg
[1] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[2] Anders Wallin,et al. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. , 2005, Clinical chemistry.
[3] C. Sorg,et al. Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease. , 2015, Cerebral cortex.
[4] A. Wall,et al. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers , 2012, Neurology.
[5] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[6] C. Sorg,et al. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease , 2014, Alzheimer's & Dementia.
[7] J. Stuart. PROCEEDINGS - PART II , 1993 .
[8] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[9] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[10] Abraham Z. Snyder,et al. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion , 2012, NeuroImage.
[11] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[12] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[13] M. Bondi,et al. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors , 2015, Alzheimer's & Dementia.
[14] Cindee M. Madison,et al. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.
[15] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[16] Keith A. Johnson,et al. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.
[17] J. Trojanowski,et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. , 2010, Archives of neurology.
[18] C. Rowe,et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease , 2011, Annals of neurology.
[19] Thomas T. Liu,et al. A geometric view of global signal confounds in resting-state functional MRI , 2012, NeuroImage.
[20] Philip S. Insel,et al. Emerging β-amyloid pathology and accelerated cortical atrophy. , 2014, JAMA neurology.
[21] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[22] K. Blennow,et al. Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET , 2016, Scientific Reports.
[23] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[24] R. N. Spreng,et al. The default network and self‐generated thought: component processes, dynamic control, and clinical relevance , 2014, Annals of the New York Academy of Sciences.
[25] Robert A. Koeppe,et al. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET , 2015, Alzheimer's & Dementia.
[26] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[27] C. Jack,et al. Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid , 2011, Alzheimer's & Dementia.
[28] Philip S. Insel,et al. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. , 2015, JAMA neurology.
[29] Jee Hoon Roh,et al. Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.
[30] Marisa O. Hollinshead,et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. , 2011, Journal of neurophysiology.
[31] Bert Sakmann,et al. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease , 2012, Proceedings of the National Academy of Sciences.
[32] Henrik Zetterberg,et al. Fluid biomarkers in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[33] Guojun Bu,et al. Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo , 2008, Neuron.
[34] Hanna Cho,et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.
[35] A. Fagan,et al. Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease , 2009, EMBO molecular medicine.
[36] K. Blennow,et al. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis , 2013, Multiple sclerosis.
[37] K. Blennow,et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. , 2014, JAMA neurology.
[38] A. Evans,et al. Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] Olivier Salvado,et al. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.
[40] M. Raichle. The brain's default mode network. , 2015, Annual review of neuroscience.
[41] C. Jack,et al. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. , 2015, JAMA neurology.
[42] K. Blennow,et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease , 2015, Neurology.
[43] M. Modat,et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[44] O. Hansson,et al. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography , 2016, Brain : a journal of neurology.
[45] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[46] R. Kraftsik,et al. Primary motor cortex involvement in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[47] A. Fagan,et al. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.
[48] D. Salmon,et al. Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment Nih Public Access , 2022 .
[49] C. Sorg,et al. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease , 2014, Alzheimer's & Dementia.
[50] R W Cox,et al. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. , 1996, Computers and biomedical research, an international journal.
[51] Thomas T. Liu,et al. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI , 2007, NeuroImage.
[52] P. Dupont,et al. Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease☆ , 2013, NeuroImage: Clinical.
[53] Cindee M. Madison,et al. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. , 2014, Cerebral cortex.
[54] Nick C Fox,et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.
[55] Mark W. Woolrich,et al. FSL , 2012, NeuroImage.
[56] J. Gee,et al. The Insight ToolKit image registration framework , 2014, Front. Neuroinform..
[57] B. Hyman,et al. Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions , 2013, Neurobiology of Disease.
[58] Karl J. Friston,et al. Movement‐Related effects in fMRI time‐series , 1996, Magnetic resonance in medicine.
[59] K. Blennow,et al. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis , 2009, Multiple sclerosis.
[60] G. Antoni,et al. Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease , 2016, Nature Communications.
[61] Daniel Rueckert,et al. Medical Image Computing and Computer-Assisted Intervention − MICCAI 2017: 20th International Conference, Quebec City, QC, Canada, September 11-13, 2017, Proceedings, Part II , 2017, Lecture Notes in Computer Science.
[62] Frithjof Kruggel,et al. Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. , 2012, Biochimica et biophysica acta.
[63] Xiao Han,et al. Atlas Renormalization for Improved Brain MR Image Segmentation Across Scanner Platforms , 2007, IEEE Transactions on Medical Imaging.
[64] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[65] Philip S. Insel,et al. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. , 2015, Brain : a journal of neurology.
[66] Edward T. Bullmore,et al. Network-based statistic: Identifying differences in brain networks , 2010, NeuroImage.
[67] M. Greicius,et al. Persistent default‐mode network connectivity during light sedation , 2008, Human brain mapping.
[68] Keith A. Johnson,et al. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.
[69] M. Bondi,et al. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype. , 2016, Journal of Alzheimer's disease : JAD.
[70] William J. Jagust,et al. Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios , 2015, The Journal of Nuclear Medicine.
[71] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[72] Charles DeCarli,et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. , 2015, Brain : a journal of neurology.
[73] Alex Becker,et al. In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.